Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,388 papers from all fields of science
Search
Sign In
Create Free Account
exemestane
Known as:
Exemestano
, exemestane [Chemical/Ingredient]
, examestane
Expand
A drug used to treat advanced breast cancer and to prevent recurrent breast cancer in postmenopausal women who have already been treated with…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Broader (3)
Androstadienes
Antineoplastic Agents
Aromatase Inhibitors
Narrower (3)
Aromasin
FCE 24304
PNU 155971
Drug Allergy
Mammary Neoplasms
NCIt Antineoplastic Agent Terminology
Pregnancy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.
J. Bliss
,
L. Kilburn
,
+12 authors
T. Menschik
Journal of Clinical Oncology
2012
Corpus ID: 207028615
PURPOSE Intergroup Exemestane Study (IES), an investigator-led study in 4,724 postmenopausal patients with early-stage breast…
Expand
Review
2008
Review
2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
A. Eisen
,
M. Trudeau
,
W. Shelley
,
H. Messersmith
,
K. Pritchard
Cancer Treatment Reviews
2008
Corpus ID: 28528478
Highly Cited
2008
Highly Cited
2008
The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
Xin Wang
,
S. Masri
,
S. Phung
,
Shiuan Chen
Cancer Research
2008
Corpus ID: 10574058
Exemestane-resistant breast cancer cell lines (i.e., ExeR), derived from MCF-7 cells expressing a high level of aromatase (MCF…
Expand
Review
2006
Review
2006
What do we know about the mechanisms of aromatase inhibitor resistance?
Shiuan Chen
,
S. Masri
,
Xin Wang
,
S. Phung
,
Yate-Ching Yuan
,
Xiwei Wu
Journal of Steroid Biochemistry and Molecular…
2006
Corpus ID: 21465992
Highly Cited
2006
Highly Cited
2006
Leuprolide acetate plus aromatase inhibition for male breast cancer.
S. Giordano
,
G. Hortobagyi
Journal of Clinical Oncology
2006
Corpus ID: 6822875
TO THE EDITOR: Approximately 1% of breast cancer occurs in male patients, yet little information is available on the optimal…
Expand
Review
2005
Review
2005
Current directions for COX-2 inhibition in breast cancer.
L. Chow
,
W. Loo
,
M. Toi
Biomedicine & pharmacotherapy = Biomedecine…
2005
Corpus ID: 19346295
Review
2004
Review
2004
Aromatase inhibitors for chemoprevention.
P. Goss
,
K. Strasser-Weippl
Best practice & research. Clinical endocrinology…
2004
Corpus ID: 39943468
Review
2003
Review
2003
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients
T. Nakata
,
S. Takashima
,
+7 authors
T. Saeki
Journal of Steroid Biochemistry and Molecular…
2003
Corpus ID: 10978205
Review
2003
Review
2003
Breast cancer prevention—clinical trials strategies involving aromatase inhibitors
P. Goss
Journal of Steroid Biochemistry and Molecular…
2003
Corpus ID: 45066312
Review
2002
Review
2002
Endocrine and clinical endpoints of exemestane as neoadjuvant therapy.
W. Miller
,
J. M. Dixon
Cancer Control: Journal of the Moffitt Cancer…
2002
Corpus ID: 24139348
A series of in vitro and in vivo studies have been performed to establish the endocrine and clinical endpoints of the type I anti…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE